Journal of Medicinal Chemistry · 2006 · 151 citations · 15 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryNeoplasiaComputational Drug DiscoveryEnzyme InhibitionHigh-throughput ScreeningMolecular DockingProtein Kinase CascadesVirtual ScreeningKinase Inhibitor Library DesignKinase InhibitorsPathogenic EffectsProtein Kinase InhibitorsVirtual Screening Validation
Casein kinase 2 (CK2) is a ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and other diseases. Using a virtual screening approach, we have identified the ellagic acid, a naturally occurring tannic acid derivative, as a novel potent CK2 inhibitor. At present, ellagic acid represents the most potent known CK2 inhibitor (K(i) = 20 nM).
15
Mark McGann, Harold R. Almond, Anthony Nicholls et al. · Biopolymers · 2002 · 492 citations
Selfish Behavior of Restriction-Modification Systems
Taku Naito, Kohji Kusano, Ichizo Kobayashi · Science · 1995 · 373 citations